Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol
Clinical trial NCT02533427 · COMPLETED
Trial details
- NCT number
- NCT02533427
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-29
- Primary completion
- 2016-03-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.